Closing Bell: Developer Seeks Rezone for Two Pfizer Blocks in Triangle, Plans 800 Apartments

by

Developer Rabsky Group has filed an application to rezone two blocks in Williamsburg’s Broadway Triangle, both part of the former Pfizer campus, to make way for two big mixed-use buildings with nearly 800 apartments, The Real Deal reported. Rabsky paid $12,750,000 in July 2012 for two properties there, which occupy the entirety of both blocks and are currently zoned for manufacturing.

The vacant properties, whose addresses are 249 and 334 Wallabout Street, total about 150,000 square feet. One of them is used for parking, and the Flushing G stop stops on the block.

If the rezoning were to go through, the properties could accommodate 622 market-rate units, 155 affordable ones and 32,000 square feet of retail, according to TRD. Back in 2012, the mammoth former Pfizer plant next door at 630 Flushing Avenue was converted to light industrial space, and the building is now home to a fashion accelerator, small food businesses, furniture makers and Brooklyn Grange.

Rabsky is also building on the next block, at 376-382 Wallabout Street, and is one of the partners developing apartments at the nearby Rheingold brewery complex in Bushwick, among other projects in Brooklyn. The Broadway Triangle has a contentious history, as various groups have clashed over building housing there.

Dushinsky’s Rabsky Group Plans Nearly 800 Units on Former Pfizer Site [TRD]
Pfizer Coverage [Brownstoner]
Broadway Triangle Coverage [Brownstoner]

Photo by Christopher Bride for PropertyShark

What's Happening